A detailed history of Strs Ohio transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Strs Ohio holds 4,100 shares of ALXO stock, worth $4,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,100
Previous 4,100 -0.0%
Holding current value
$4,469
Previous $24,000 70.83%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$5.84 - $17.56 $23,944 - $71,996
4,100 New
4,100 $24,000
Q3 2021

Oct 22, 2021

BUY
$52.51 - $80.91 $26,255 - $40,455
500 New
500 $36,000
Q2 2021

Jul 26, 2021

SELL
$52.2 - $75.23 $516,780 - $744,777
-9,900 Closed
0 $0
Q1 2021

Apr 23, 2021

BUY
$62.84 - $87.68 $471,300 - $657,600
7,500 Added 312.5%
9,900 $730,000
Q3 2020

Dec 14, 2020

BUY
$29.36 - $47.1 $70,464 - $113,040
2,400 New
2,400 $90,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $44.4M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.